Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4072822
Max Phase: Preclinical
Molecular Formula: C64H104Cl4N12O4
Molecular Weight: 1101.58
Molecule Type: Small molecule
Associated Items:
ID: ALA4072822
Max Phase: Preclinical
Molecular Formula: C64H104Cl4N12O4
Molecular Weight: 1101.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)c1cc2c(OCCCCNC(=N)N)c(c1)Cc1cc(C(C)(C)C)cc(c1OCCCCNC(=N)N)Cc1cc(C(C)(C)C)cc(c1OCCCCNC(=N)N)Cc1cc(C(C)(C)C)cc(c1OCCCCNC(=N)N)C2.Cl.Cl.Cl.Cl
Standard InChI: InChI=1S/C64H100N12O4.4ClH/c1-61(2,3)49-33-41-29-43-35-50(62(4,5)6)37-45(54(43)78-26-18-14-22-74-58(67)68)31-47-39-52(64(10,11)12)40-48(56(47)80-28-20-16-24-76-60(71)72)32-46-38-51(63(7,8)9)36-44(55(46)79-27-19-15-23-75-59(69)70)30-42(34-49)53(41)77-25-17-13-21-73-57(65)66;;;;/h33-40H,13-32H2,1-12H3,(H4,65,66,73)(H4,67,68,74)(H4,69,70,75)(H4,71,72,76);4*1H
Standard InChI Key: FWPHQNSLJDXGMD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1101.58 | Molecular Weight (Monoisotopic): 1100.7990 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Sestito SE, Facchini FA, Morbioli I, Billod JM, Martin-Santamaria S, Casnati A, Sansone F, Peri F.. (2017) Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling., 60 (12): [PMID:28471658] [10.1021/acs.jmedchem.7b00095] |
Source(1):